ConductScience.org, home

Paper40333329

Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.

Adderson E and 11 others. Vaccines (Basel), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1. Papers, record 40333329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40333329

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-05-13
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adderson EElisabeth
2Allison KJKim J
3Branum KKristen
4Sealy RERobert E
5Jones BGBart G
6Surman SLSherri L
7Penkert RRRhiannon R
8Hayden RTRandall Thttps://orcid.org/0000-0002-3073-4115
9Russell CJCharles Jhttps://orcid.org/0000-0001-5683-3990
10Portner AAllen
11Slobod KSKaren S
12Hurwitz JLJulia L

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI031596NIAID NIH HHSUnited StatesP01AI031596PubMed and NIHNIH RePORTER
P01 AI054955NIAID NIH HHSUnited StatesP01AI054955PubMed and NIHNIH RePORTER
R01 AI088729NIAID NIH HHSUnited StatesR01AI088729PubMed and NIHNIH RePORTER
R21 AI056974NIAID NIH HHSUnited StatesR21AI056974PubMed and NIHNIH RePORTER
R34 AI081875NIAID NIH HHSUnited StatesR34AI081875PubMed and NIHNIH RePORTER
P30 CA021765NCI NIH HHSUnited StatesP30CA021765PubMedNIH RePORTER
ALSACAmerican Lebanese Syrian Associated CharitiesPubMedPubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00186927A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and ToddlersDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16304611Croup: an 11-year study in a pediatric practice.Pediatrics1983https://conductscience.org/library/papers/6304611PubMed
237436413[Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: Respirovirus) strain Moscow].Vopr Virusol2023https://conductscience.org/library/papers/37436413PubMed
326908486Estimates of Parainfluenza Virus-Associated Hospitalizations and Cost Among Children Aged Less Than 5 Years in the United States, 1998-2010.J Pediatric Infect Dis Soc2016https://conductscience.org/library/papers/26908486PubMed
438543921Reduction in Interferon-Stimulated Genes Contributes to High-Yield Production of Influenza Virus in Suspension MDCK Cells.Vaccines (Basel)2024https://conductscience.org/library/papers/38543921PubMed
512029153Primary replication of a recombinant Sendai virus vector in macaques.J Gen Virol2002https://conductscience.org/library/papers/12029153PubMed
618508560Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.Front Biosci2008https://conductscience.org/library/papers/18508560PubMed
714449901Growth characteristics of monkey kidney cell strains LLC-MK1, LLC-MK2, and LLC-MK2(NCTC-3196) and their utility in virus research.J Exp Med1962https://conductscience.org/library/papers/14449901PubMed
835973352The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design.Curr Opin Immunol2022https://conductscience.org/library/papers/35973352PubMed
922128250The polio-eradication programme and issues of the end game.J Gen Virol2012https://conductscience.org/library/papers/22128250PubMed
1028133811Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Immunol Rev2017https://conductscience.org/library/papers/28133811PubMed
1120399493Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.Lancet2010https://conductscience.org/library/papers/20399493PubMed
1226850558Immunogenicity of a recombinant Sendai virus expressing the capsid precursor polypeptide of foot-and-mouth disease virus.Res Vet Sci2016https://conductscience.org/library/papers/26850558PubMed
1331786669Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.J Mol Med (Berl)2019https://conductscience.org/library/papers/31786669PubMed
144305199
Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.
Am J Epidemiol1969https://conductscience.org/library/papers/4305199PubMed
1521963661Biological feasibility of measles eradication.Virus Res2011https://conductscience.org/library/papers/21963661PubMed
16219669Sendai virus.Adv Virus Res1978https://conductscience.org/library/papers/219669PubMed
1738543806Evaluation of Vaccine Immunogenicity-Correlates to Real-World Protection: Influenza.Viruses2024https://conductscience.org/library/papers/38543806PubMed
1812082313Induction of HIV-1-specific neutralizing antibodies in mice vaccinated with a recombinant Sendai virus vector.Jpn J Infect Dis2002https://conductscience.org/library/papers/12082313PubMed
1931767462Updates on immunologic correlates of vaccine-induced protection.Vaccine2020https://conductscience.org/library/papers/31767462PubMed
2020682364Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.Vaccine2010https://conductscience.org/library/papers/20682364PubMed

See all 58 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42597254Insights Into monoclonal antibodies and vaccines targeting respiratory viruses.Front Pediatr2026https://conductscience.org/library/papers/42597254PubMed
42300833High prevalence and clinical impact of microbial co-detection in hospitalized children with human parainfluenza virus type 1.Microbiol Spectr2026https://conductscience.org/library/papers/42300833PubMed
40663463Precision engineering of human cytomegalovirus without BAC constraints: a Sendai virus-delivered CRISPR/Cas9 approach.J Gen Virol2025https://conductscience.org/library/papers/40663463PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40333329

GET https://conductscience.org/api/papers/v1/40333329/references?page=2